A prospective, observational study to evaluate adverse drug reactions in patients with COVID-19 treated with remdesivir or hydroxychloroquine: a preliminary report

Portuguese study reported a greater incidence of adverse drug reactions with hydroxychloroquine vs remdesivir (n=149; total of 102 events; 47.5% vs 12.5%; p<0.001). This trend persisted after adjusting for gender, age, baseline medication and BMI.

Source:

European Journal of Hospital Pharmacy